Proteogenomics identifies c-Met inhibition as a therapeutic strategy for BAP1-deficient clear cell renal cell carcinoma

• Bowen Du,
• Yulin Zhou,
• Wenzhi Li,
• Haowei He,
• Ming Chen,
• Ninghan Feng

Affiliations

Bowen Du

Department of Urology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University

Yulin Zhou

Department of Urology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University

Wenzhi Li

Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Haowei He

Department of Urology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University

Ming Chen

Department of Urology, Affiliated Zhongda Hospital of Southeast University

Ninghan Feng

Department of Urology, Jiangnan University Medical Center